PredxBio

Access our brand new White Paper here

Menu

Spatial Intelligence Summit: Shaping the Future of Drug Discovery & Development

Hosted by PredxBio

EVENT ENDED

November 5, 2025
The Assembly, Pittsburgh, PA

Register Now

“No power on earth can resist an idea whose time has come.”
– Victor Hugo

Spatial biology is no longer a concept of the future, it is here, now, transforming how we understand disease, discover new drugs, and personalize therapies.

We are convening scientists, engineers, entrepreneurs, and visionaries who are building the industries of the future in spatial biology and AI. The Spatial Intelligence Summit is a first-of-its-kind gathering uniting leaders in cancer research, pharma, and AI for a day of science, collaboration, and networking.

The Voices Shaping Spatial Medicine

At the Summit, speakers will deliver high-impact talks that distill complex science into bold insights and conclude with forward-looking predictions designed to spark discussion. Each talk brings a unique perspective from the front lines of cancer research, pharma, and AI. Together, these voices will highlight the breakthroughs reshaping medicine and the opportunities that lie ahead.

Featured Presenters

Linkedin-in

Arutha Kulasinghe, PhD

Founding Scientific Director
Queensland Spatial Biology Centre

Linkedin-in

Tullia Bruno, PhD

Assistant Professor of Immunology
University of Pittsburgh School of Medicine

Linkedin-in

Prasad S. Adusumilli, MD

Vice Chair for Translational Research
Memorial Sloan Kettering Cancer Center

Linkedin-in

Hoifung Poon, PhD

General Manager
Microsoft Research

Linkedin-in

Ven Raju

President & CEO
Innovation Works

Linkedin-in

Carlo Bifulco, MD

Chief Medical Officer
Providence Genomics

Linkedin-in

Laura Dillon, PhD

Senior Director, Partnership Strategy Lead
AstraZeneca

Linkedin-in

Samir Hanash, MD, PhD

Director and Distinguished Chair, Clinical Cancer Prevention
MD Anderson Cancer Center

Linkedin-in

Vipul Baxi, MS, MBA

Executive Director, Computational Imaging and Digital Biomarkers
AMGEN

Linkedin-in

Davide Bedognetti, MD, PhD

Executive Director, Translational Medicine
Kite Pharma - A Gilead Company

Linkedin-in

Amanda Poholek, PhD

Associate Professor of Immunology
University of Pittsburgh School of Medicine

Linkedin-in

Jill Stefanelli, PhD

CEO
Modella AI

Linkedin-in

Michael Surace, PhD

Director, Cancer Biomarker Development
AstraZeneca

Linkedin-in

William Mifsud, MD, PhD

Senior Director, Pathology
Kite Pharma - A Gilead Company

Linkedin-in

S. Chakra Chennubhotla, PhD

Chief of AI, COO, and
Co-Founder
PredxBio

Linkedin-in

B. Dusty Majumdar, PhD

CEO
PredxBio

The Arrival of Spatial Medicine

Every era is defined by an idea that changes everything. The Industrial Revolution transformed economies. The internet accelerated global innovation. Today, spatial biology is that defining idea, one that is setting the stage for an entirely new era of discovery and human health. By mapping biology in its true context, at cellular and tissue scale, we are laying the foundations for the next generation of precision therapies.

At the forefront of this movement, PredxBio is advancing AI – driven spatial biomarker discovery through our SpaceIQ™ Platform, transforming complex spatial data into actionable insights. This Summit is part of our commitment to building a collaborative ecosystem — bringing together leaders from pharma, biotech, academia, and clinical research to shape the next frontier of cancer care.

AGENDA – NOV 5, 2025

Time Session Presenters
8:00 – 8:25 Registration & Badge Pickup —
8:30 – 8:40 Summit Kickoff

Dusty Majumdar, PhD (CEO, PredxBio) &

Stanley Marks (Chairman, UPMC Hillman Cancer Center)
8:40 – 9:05

Shaping the Future of Drug Discovery & Development

 Dusty Majumdar, PhD (PredxBio)
9:05 – 9:30 Keynote Presentation Arutha Kulasinghe, PhD (University of Queensland)
9:30 – 9:50 Spotlight Session Tullia Bruno, PhD (University of Pittsburgh)
9:50 – 10:05 Coffee Break  Networking
10:05 – 10:35 Spotlight Session

Chakra Chennubhotla, PhD (PredxBio) &

Filippo Pullara, PhD (PredxBio)
10:35 – 10:55 Spotlight Session Hoifung Poon, PhD (Microsoft Research)
10:55 – 11:15 Spotlight Session Carlo Bifulco, MD (Providence Genomics)
11:15 – 11:45

Industry Leaders Roundtable:

Driving the Future of Drug Discovery

Moderator:

Laura Dillon, PhD (AstraZeneca)

Panelists:

Davide Bedognetti, MD, PhD (Kite Pharma – A Gilead Company)

Vipul Baxi, MS, MBA (Amgen)

Jill Stefanelli, PhD (Modella AI)

Michael Surace, PhD (AstraZeneca)

William Mifsud, MD (Kite Pharma – A Gilead Company)
11:45 – 12:30 Lunch Networking 
12:30 – 12:50 Fireside Chat

Dusty Majumdar, PhD (PredxBio) &

Brian McKelligon (Former CEO of Akoya Biosciences)
12:50 – 1:10 Spotlight Session Michael Surace, PhD (AstraZeneca)
1:10 – 1:30 Spotlight Session Sam Hanash, MD, PhD (MD Anderson Cancer Center)
1:30 – 1:45 Coffee Break Desserts & Networking
1:45 – 2:05 Spotlight Session Jill Stefanelli, PhD (Modella AI)
2:05 – 2:25 Spotlight Session Prasad Adusumalli, MD (Memorial Sloan Kettering Cancer Center)
2:25 – 2:50

Fireside Chat:

Market Dynamics and Investment Climate

Ven Raju (Innovation Works),

Brianna McDonald (NW Angel Fund), 

Dave Edwards (WD Investments), &

Laura Dillon, PhD (AstraZeneca), with

Dusty Majumdar, PhD (PredxBio)
2:50 – 3:10 Spotlight Session Amanda Poholek, PhD (University of Pittsburgh)
3:10 – 3:40

Looking Ahead:

Charting What’s Next

Arutha Kulasinghe, PhD (University of Queensland),

Hoifung Poon, PhD (Microsoft),

Brian McKelligon (Former CEO of Akoya Biosciences), &

Sam Hanash, MD, PhD (MD Anderson Cancer Center), with

Dusty Majumdar, PhD (PredxBio)

Building the Future Together

The Summit takes place at The Assembly, Pittsburgh’s landmark life sciences venue. More than a building, it is a symbol of collaboration—where bold ideas come together to shape the future of medicine.

Pittsburgh itself is emerging as one of the world’s most dynamic life sciences hubs, anchored by institutions like the University of Pittsburgh, Carnegie Mellon University, and UPMC Hillman Cancer Center, and energized by a thriving biotech and digital health community. It is here, in a city built on reinvention, that the next breakthroughs in cancer research and precision medicine are being forged.

About PredxBio

PredxBio is a global leader in AI-powered spatial biology, transforming complex tissue imaging and multi-modal data into actionable insights. Our proprietary platform enables pharmaceutical companies and research institutions to accelerate drug discovery, optimize clinical trials, and predict patient outcomes with unprecedented precision. By revealing the network biology of cancer, we are setting new standards for biomarker discovery and personalized medicine.

Registration

Join us for the Spatial Intelligence Summit. Complimentary and paid registration categories are listed below – hurry, early bird pricing ends on September 30.

Subscribe to our Newsletter

* indicates required

We received your request! One of our team members will be in touch as soon as possible.

Submit your Resume

Download Whitepaper

Download Whitepaper

B. Dusty Majumdar, PhD

CHIEF EXECUTIVE OFFICER

Linkedin-in

B. Dusty Majumdar, PhD  is a seasoned leader in Precision Healthcare with more than 20 years of experience in building and successfully launching innovative technologies across oncology, multi-omics, Real-World Evidence (RWE). diagnostic imaging and liquid biopsy platforms leveraging some of the industry’s most advanced AI platforms, genomic and clinical simulations (digital twins), and emerging medical imaging technologies. Dr. Majumdar’s experience includes leading strategy and marketing as the Chief Marketing Officer (CMO) at IBM and multiple commercial and technical leadership roles at GE Healthcare, Exact Sciences and 3M. He has also led the commercial and strategic functions in a range of start-ups in the healthcare/biopharma space over the last few years.  Dr. Majumdar is a widely respected global leader in the healthcare industry and holds a Ph.D. from the University of Texas at Austin and a bachelor’s degree from the Indian Institute of Technology (IIT), Kharagpur.  He has authored several peer-reviewed scientific publications and holds multiple patents.

Joe Camaratta

Sr. VP Business Development

Linkedin-in

Joe Camaratta specializes in medical technology innovation and commercialization, taking products from concept to clinical adoption. He held executive positions for GE Healthcare and Siemens Healthcare and built businesses in medical imaging, cardiology, and oncology. He founded and led two early stage medical technology companies that apply artificial intelligence to improve clinical decision-making.

Joe holds a Master of Science degree in Computer Science from Rutgers University and a Bachelor of Science degree in Computer Science from Drexel University. He currently serves as an advisor to the Entreprenuerial Investing Program of the Crohn’s & Colitis Foundation, and the University Science Center QED Program focused on commercialization of academic innovations

Bruce Campbell, MS

VP Software Engineering

Linkedin-in

Bruce leads the software engineering and quality assurance teams at PredxBio. As the VP of Software Engineering, he is responsible for analytical infrastructure, product development and the commercialization of machine learning, image processing, and computational biology algorithms. Prior to joining PredxBio, Bruce was at IBM and Xylem in global Director of Data Science roles. He has over 20 years of experience in digital pathology algorithms and is highly motivated to deliver care through digital and computational pathology. He has multiple successful FDA 510k device applications, and multiple CLIA certified algorithms deployed in clinical practice.

Bruce holds a BS in Physics and MS in Applied Mathematics from the University of Rochester, an MS in Statistics from North Carolina State University, and is currently pursuing graduate mathematics studies at The Ohio State University. Bruce loves the outdoors. You can find him hiking and rock climbing in Appalachia.